Search

Your search keyword '"de Kreutzenberg, Saula Vigili"' showing total 185 results

Search Constraints

Start Over You searched for: Author "de Kreutzenberg, Saula Vigili" Remove constraint Author: "de Kreutzenberg, Saula Vigili"
185 results on '"de Kreutzenberg, Saula Vigili"'

Search Results

1. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

2. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

Catalog

Books, media, physical & digital resources

3. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

6. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

7. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

8. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

10. Supplemental Materials for Dei Cas A (JCEM 2023) Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes

12. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.

20. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1

22. Additional file 1 of PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes

24. Diabetes impairs stem cell and proangiogenic cell mobilization in humans

27. Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention.

34. [Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]

35. L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled [sup.15]N arginine approach. (Pathophysiology)

38. Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy

39. Documento di consenso e raccomandazioni per la prevenzione cardiovascolare in Italia 2018 [Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]

40. Hepatic sensitivity to insulin: effects of sulfonylurea drugs

41. Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention.

44. Blood expression of matrix metalloproteinases 8 AND 9 and of their inducers S100A8 and S100A9 Supports diagnosis and prognosis of PDAC-associated diabetes mellitus

45. miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways.

46. Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesivenessin vitro: relevance to human metabolic syndrome

48. NETosis Delays Diabetic Wound Healing in Mice and Humans.